Status:
COMPLETED
Comparison of Efficacy of Cefotaxime, Ceftriaxone, and Ciprofloxacin for the Treatment of SBP in Patients With LC
Lead Sponsor:
Korea University
Conditions:
SBP
Liver Cirrhosis
Eligibility:
All Genders
16-70 years
Phase:
PHASE4
Brief Summary
Spontaneous bacterial peritonitis (SBP) is one of the most serious complications of liver cirrhosis. Mainstay of treatment for SBP is use of proper antibiotics. Although, several antibiotics including...
Detailed Description
Spontaneous bacterial peritonitis (SBP) is one of the most serious complications of liver cirrhosis. Mainstay of treatment for SBP is use of proper antibiotics. Although, several antibiotics including...
Eligibility Criteria
Inclusion
- Liver cirrhosis patients with ascites
- Ascitic fluid PMN cell count \>250/mm3
- Age: 16\~70 years old
Exclusion
- Allergic to 3rd generation cephalosporin or quinolone
- Antibiotics within 2 weeks
- Open abdominal surgery within 4 weeks
- Evidence of 2ndary peritonitis, intrabdominal hemorrhage, pancreatitis, Tb peritonitis, or peritoneal carcinomatosis
- HCC with portal vein thrombosis
- Pregnant woman
- HIV positive
Key Trial Info
Start Date :
April 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2018
Estimated Enrollment :
261 Patients enrolled
Trial Details
Trial ID
NCT01265173
Start Date
April 1 2007
End Date
June 1 2018
Last Update
April 6 2020
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Korea University Ansan Hospital
Ansan, South Korea
2
Korea University Anam Hospital
Seoul, South Korea, 136705